M.W. van Gisbergen
Recent publications
-
van Gisbergen, M. W., Rossel, S. V. J., Theunissen, T. E. J., Janssen, R., Kaseke, T., van der Smagt, J. J., Steijlen, P. M., Vreeburg, M., Gostynski, A. H., & van Geel, M. (2025). Expanding phenotypic insights of palmoplantar keratodermas based on novel FAM83G variants. British Journal of Dermatology, 192(3), 544-546. https://doi.org/10.1093/bjd/ljae419More information about this publication
-
van der Velden, J. J. A. J., van Gisbergen, M. W., Kamps, M. A. F., Janssen, R., Diercks, G. F. H., Steijlen, P. M., van Geel, M., & Bolling, M. C. (2024). Variants in the L12 linker domain of KRT10 are causal to atypical epidermolytic ichthyosis. Journal of Dermatology, 51(9), 1180-1186. https://doi.org/10.1111/1346-8138.17395More information about this publication
-
Clabbers, J., Boesjes, C., Spekhorst, L., van Gisbergen, M. W., Maas, E., Marshall, J., Janssen, R., Janssen, M., Zuithoff, N. P. A., Steijlen, P., de Graaf, M., van Geel, M., de Bruin-Weller, M., & Gostynski, A. (2024). Influence of pathogenic filaggrin variants on dupilumab treatment in atopic dermatitis. Journal of Allergy and Clinical Immunology, 153(4), 1155-1161.e4. https://doi.org/10.1016/j.jaci.2023.12.027More information about this publication
-
Côrte-Real, B. F., Hamad, I., Arroyo Hornero, R., Geisberger, S., Roels, J., Van Zeebroeck, L., Dyczko, A., van Gisbergen, M. W., Kurniawan, H., Wagner, A., Yosef, N., Weiss, S. N. Y., Schmetterer, K. G., Schröder, A., Krampert, L., Haase, S., Bartolomaeus, H., Hellings, N., Saeys, Y., ... Kleinewietfeld, M. (2023). Sodium perturbs mitochondrial respiration and induces dysfunctional Tregs. Cell Metabolism, 35(2), 299-315.e8. https://doi.org/10.1016/j.cmet.2023.01.009More information about this publication
-
Vallbona-Garcia, A., Lindsey, P. J., Kamps, R., Stassen, A. P. M., Nguyen, N., van Tienen, F. H. J., Hamers, I. H. J., Hardij, R., van Gisbergen, M. W., Benedikter, B. J., de Coo, I. F. M., Webers, C. A. B., Gorgels, T. G. M. F., & Smeets, H. J. M. (2023). Mitochondrial DNA D-loop variants correlate with a primary open-angle glaucoma subgroup. Frontiers in Ophthalmology, 3, Article 1309836. https://doi.org/10.3389/fopht.2023.1309836More information about this publication
-
Keulers, T. G., Koch, A., van Gisbergen, M. W., Barbeau, L. M. O., Zonneveld, M. I., de Jong, M. C., Savelkouls, K. G. M., Wanders, R. G., Bussink, J., Melotte, V., & Rouschop, K. M. A. (2022). ATG12 deficiency results in intracellular glutamine depletion, abrogation of tumor hypoxia and a favorable prognosis in cancer. Autophagy, 18(8), 1898-1914. https://doi.org/10.1080/15548627.2021.2008690More information about this publication
-
van Gisbergen, M. W., Zwilling, E., & Dubois, L. J. (2021). Metabolic Rewiring in Radiation Oncology Toward Improving the Therapeutic Ratio. Frontiers in Oncology, 11, Article 653621. https://doi.org/10.3389/fonc.2021.653621More information about this publication
-
van Gisbergen, M. W., Offermans, K., Voets, A. M., Lieuwes, N. G., Biemans, R., Hoffmann, R. F., Dubois, L. J., & Lambin, P. (2020). Mitochondrial Dysfunction Inhibits Hypoxia-Induced HIF-1α Stabilization and Expression of Its Downstream Targets. Frontiers in Oncology, 10, Article 770. https://doi.org/10.3389/fonc.2020.00770More information about this publication
-
Grasso, D., Medeiros, H. C. D., Zampieri, L. X., Bol, V., Danhier, P., van Gisbergen, M. W., Bouzin, C., Brusa, D., Gregoire, V., Smeets, H., Stassen, A. P. M., Dubois, L. J., Lambin, P., Dutreix, M., & Sonveaux, P. (2020). Fitter Mitochondria Are Associated With Radioresistance in Human Head and Neck SQD9 Cancer Cells. Frontiers in Pharmacology, 11, Article 263. https://doi.org/10.3389/fphar.2020.00263More information about this publication
-
Reymen, B. J. T., van Gisbergen, M. W., Even, A. J. G., Zegers, C. M. L., Das, M., Vegt, E., Wildberger, J. E., Mottaghy, F. M., Yaromina, A., Dubois, L. J., van Elmpt, W., De Ruysscher, D., & Lambin, P. (2020). Nitroglycerin as a radiosensitizer in non-small cell lung cancer: Results of a prospective imaging-based phase II trial. Clinical and Translational Radiation Oncology, 21, 49-55. https://doi.org/10.1016/j.ctro.2019.12.002More information about this publication